Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass (Q38134579)

29 August 2017

Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass (English)

1 reference

29 August 2017

M P Hage

1

1 reference

29 August 2017

G El-Hajj Fuleihan

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

6 September 2013

1 reference

Osteoporosis International

29 August 2017

1 reference

29 August 2017

25

1 reference

29 August 2017

2

1 reference

29 August 2017

423-439

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-013-2480-9

29 August 2017

0 references

cites work

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Procedure and outcomes of Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Bariatric surgery and bone disease: from clinical perspective to molecular insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Evolution of operative procedures for the management of morbid obesity 1950-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The gut hormone peptide YY regulates appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Relationships among body mass, its components, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Elevated peptide YY levels in adolescent girls with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Hypothalamic Y2 receptors regulate bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Peptide YY regulates bone turnover in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

GIP and bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Ghrelin directly regulates bone formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Stimulation of intramembranous bone repair in rats by ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Ghrelin regulates proliferation and differentiation of osteoblastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Ghrelin and metabolic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Amylin in bone conservation current evidence and hypothetical Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The insulin-like growth factor-I gene and osteoporosis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Modulation of osteoclastogenesis by fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Relationships between fat and bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Relation of serum serotonin levels to bone density and structural parameters in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

SSRIs, bone mineral density, and risk of fractures--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Changes in bone mineral content after surgical treatment of morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Bone and gastric bypass surgery: effects of dietary calcium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Changes in bone mineral density in women following 1-year gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Influence of fat on bone measurements with dual-energy absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Osteocytes, mechanosensing and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Evidence for alteration of the vitamin D-endocrine system in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The long-term effects of gastric bypass on vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

IOF position statement: vitamin D recommendations for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Nutritional deficiencies following bariatric surgery: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Serum magnesium status after gastric bypass surgery in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Dietary protein and bone health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Osteoporosis and trace elements--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Reciprocal regulation of bone and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Physiological roles of the leptin endocrine system: differences between mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The complex effects of leptin on bone metabolism through multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin is a potent stimulator of bone growth in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin regulates bone formation via the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin-dependent co-regulation of bone and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Convergence between bone and energy homeostases: leptin regulation of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Relationship between leptin levels and bone mineral density in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Adiponectin and its receptors are expressed in bone-forming cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

In vitro and in vivo effects of adiponectin on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Sex steroids and the construction and conservation of the adult skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Sex hormones and bariatric surgery in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

The mutual dependence between bone and gonads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Testosterone enhances calcium reabsorption by the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Sex hormones and bone health in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Impact of male obesity on infertility: a critical review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Male obesity and alteration in sperm parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Leptin Inhibits Osteoclast Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-013-2480-9

Synthesis and evaluation of disulfide bond mimetics of amylin-(1–8) as agents to treat osteoporosis

21 January 2018

1 reference

12 December 2020

Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.

1 reference

12 December 2020

Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat

1 reference

12 December 2020

Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice

1 reference

12 December 2020

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

1 reference

12 December 2020

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast

1 reference

12 December 2020

Biochemical Evidence of Metabolic Bone Disease in Women Following Roux-Y Gastric Bypass for Morbid Obesity

1 reference

12 December 2020

Leptin reduces ovariectomy-induced bone loss in rats

1 reference

12 December 2020

Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass

1 reference

12 December 2020

Insulin receptor expression in primary and cultured osteoclast-like cells

1 reference

12 December 2020

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

12 December 2020

Body composition changes following laparoscopic gastric banding for morbid obesity

1 reference

12 December 2020

Serum leptin levels are associated with bone mass in nonobese women.

1 reference

12 December 2020

Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery

1 reference

12 December 2020

Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts

1 reference

12 December 2020

Assessment of bone metabolism in obese women

1 reference

12 December 2020

Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass

1 reference

12 December 2020

Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study

1 reference

12 December 2020

Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity

1 reference

12 December 2020

Growth hormone and bone

1 reference

12 December 2020

Serum leptin level is a predictor of bone mineral density in postmenopausal women.

1 reference

12 December 2020

Elevated serum parathormone after Roux-en-Y gastric bypass

1 reference

12 December 2020

Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up

1 reference

12 December 2020

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

12 December 2020

Effects of amylin on human osteoblast-like cells

1 reference

12 December 2020

Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway

1 reference

12 December 2020

Augmentation of bone mineral density in hirsute women

1 reference

12 December 2020

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

1 reference

12 December 2020

Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women

1 reference

12 December 2020

Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women

1 reference

12 December 2020

Mechanical stimulation in vivo reduces osteocyte expression of sclerostin

1 reference

12 December 2020

Vitamin D status and bone histomorphometry in gross obesity

1 reference

12 December 2020

Ghrelin? Yes, it is spelled correctly

1 reference

12 December 2020

Effects of glucose-dependent insulinotropic peptide on osteoclast function

1 reference

12 December 2020

The impact of morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of comorbidities in an employed population

1 reference

12 December 2020

Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover

1 reference

12 December 2020

10.1007/S00198-013-2480-9

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

0 references

1 reference